Characteristic | Recurrent PTB at first episodes | P value | |
---|---|---|---|
Bacteriological negative cases (n = 3639, 52.44%) | Bacteriological positive cases (n = 3300, 47.56%) | ||
Sex | < 0.001 | ||
Male | 2649 (72.79) | 2696 (81.70) | |
Female | 990 (27.21) | 604 (18.30) | |
Age group | 0.233 | ||
0–14 years | 18 (0.49) | 2 (0.06) | |
15–29 years | 636 (17.48) | 506 (15.33) | |
30–44 years | 520 (14.29) | 499 (15.12) | |
45–59 years | 1055 (28.99) | 1054 (31.94) | |
≥ 60 years | 1410 (38.75) | 1239 (37.55) | |
Treatment history | 0.577 | ||
New case | 3463 (95.16) | 3147 (95.36) | |
Retreatment case | 176 (4.84) | 154 (4.67) | |
Time from the completion to recurrent tuberculosis (month, range) | 17.6 (8.3–32.5) | 17.5 (8.3–35.5) | 0.121 |
Median of time delay (days, range) | |||
Time from onset to first hospital visit | 10 (1–29) | 13 (1–34) | < 0.001 |
Time from onset to confirm | 26 (13–48) | 32 (15–62) | < 0.001 |
Time from onset to course end | 213 (197–245) | 216 (199–252) | < 0.001 |
Time from hospitalization to course end | 189 (184–213) | 189 (184–215) | 0.592 |
Management mode | < 0.001 | ||
Enhanced supervision | 3397 (94.41) | 29 (0.89) | |
DOTS | 196 (5.45) | 3234 (99.08) | |
Self-medication | 5 (0.14) | 1 (0.03) | |
Outcomea | < 0.001 | ||
Cured | 749 (20.82) | 1134 (34.74) | |
Treatment completed | 2308 (64.15) | 1569 (48.07) | 0.022 |
Death | 33 (0.92) | 58 (1.78) | 0.003 |
Others | 549 (15.26) | 539 (16.51) |